treprostinil oral
Selected indexed studies
- Combination Therapy with Oral Treprostinil for Pulmonary Arterial Hypertension. A Double-Blind Placebo-controlled Clinical Trial. (Am J Respir Crit Care Med, 2020) [PMID:31765604]
- Addition of inhaled treprostinil to oral therapy for pulmonary arterial hypertension: a randomized controlled clinical trial. (J Am Coll Cardiol, 2010) [PMID:20430262]
- Oral treprostinil in the treatment of pulmonary arterial hypertension. (Expert Opin Pharmacother, 2017) [PMID:28922964]
_Worker-drafted node — pending editorial review._
Connections
treprostinil oral is a side effect of
Sources
- Addition of inhaled treprostinil to oral therapy for pulmonary arterial hypertension: a randomized controlled clinical trial. (2010) pubmed
- Combination Therapy with Oral Treprostinil for Pulmonary Arterial Hypertension. A Double-Blind Placebo-controlled Clinical Trial. (2020) pubmed
- Oral treprostinil in the treatment of pulmonary arterial hypertension. (2017) pubmed
- Efficacy of oral treprostinil for treating pulmonary arterial hypertension: a systematic review and meta-analysis. (2024) pubmed
- Oral treprostinil diethanolamine for pulmonary arterial hypertension. (2015) pubmed
- Oral treprostinil improves pulmonary vascular compliance in pulmonary arterial hypertension. (2022) pubmed
- Treatment With Oral or Inhaled Treprostinil in Patients With Pulmonary Arterial Hypertension and Cardiovascular Comorbidities. (2025) pubmed
- Practical management of oral treprostinil in patients with pulmonary arterial hypertension: Lessons from ADAPT, EXPEDITE, and expert consensus. (2024) pubmed
- Pharmacokinetic evaluation of treprostinil (oral) for the treatment of pulmonary arterial hypertension. (2014) pubmed
- Oral Treprostinil is Associated with Improved Survival in FREEDOM-EV and its Open-Label Extension. (2024) pubmed